Abstract

Abstract Liver-expressed chemokine (LEC)/CCL16 is a human CC chemokine that is constitutively expressed by the liver parenchymal cells and present in the normal plasma at high concentrations. Previous studies have shown that CCL16 is a low-affinity ligand for CCR1, CCR2, CCR5, and CCR8 and attracts monocytes and T cells. Recently, a novel histamine receptor termed type 4 (H4) has been identified and shown to be selectively expressed by eosinophils and mast cells. In this study, we demonstrated that CCL16 induced pertussis toxin-sensitive calcium mobilization and chemotaxis in murine L1.2 cells expressing H4 but not those expressing histamine receptor type 1 (H1) or type 2 (H2). CCL16 bound to H4 with a Kd of 17 nM. By RT-PCR, human and mouse eosinophils express H4 but not H3. Accordingly, CCL16 induced efficient migratory responses in human and mouse eosinophils. Furthermore, the responses of human and mouse eosinophils to CCL16 were effectively suppressed by thioperamide, an antagonist for H3 and H4. Intravenous injection of CCL16 into mice induced a rapid mobilization of eosinophils from bone marrow to peripheral blood, which was also suppressed by thioperamide. Collectively, CCL16 is a novel functional ligand for H4 and may have a role in trafficking of eosinophils.

Keywords

ThioperamideHistamine H4 receptorCC chemokine receptorsCXCL2CCR2CCR1XCL2HistamineCCL17Chemokine receptorCCL21Chemokine receptor CCR5ChemokineChemistryCCL25CXCL10BiologyC-C chemokine receptor type 6Cell biologyImmunologyHistamine H3 receptorReceptorHistamine H2 receptorEndocrinologyInflammationAntagonistBiochemistry

Affiliated Institutions

Related Publications

Publication Info

Year
2004
Type
article
Volume
173
Issue
3
Pages
2078-2083
Citations
71
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

71
OpenAlex

Cite This

Takashi Nakayama, Yoshiko Kato, Kunio Hieshima et al. (2004). Liver-Expressed Chemokine/CC Chemokine Ligand 16 Attracts Eosinophils by Interacting with Histamine H4 Receptor. The Journal of Immunology , 173 (3) , 2078-2083. https://doi.org/10.4049/jimmunol.173.3.2078

Identifiers

DOI
10.4049/jimmunol.173.3.2078